Detalhe da pesquisa
1.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer;
130(3): 439-452, 2024 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37795845
2.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer;
130(10): 1747-1757, 2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38236702
3.
Physicians' Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care.
Oncologist;
29(1): e38-e46, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37405703
4.
An exploration into the relationship between insomnia and repetitive negative thinking among cancer survivors.
J Psychosoc Oncol;
: 1-14, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38831557
5.
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
J Natl Compr Canc Netw;
21(7): 725-731.e1, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37433436
6.
Validation of the Lee-Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approach.
Psychooncology;
32(2): 256-265, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36468339
7.
Qualitative similarities and distinctions between participants' experiences with a yoga intervention and an attention control.
Support Care Cancer;
31(3): 172, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36795229
8.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res;
32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36029412
9.
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
Cancer;
128(3): 536-546, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34614209
10.
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Cancer;
128(7): 1381-1391, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34890045
11.
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.
Oncologist;
27(12): 1067-1073, 2022 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36215065
12.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med;
380(25): 2395-2405, 2019 06 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31157962
13.
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
BMC Public Health;
22(1): 1359, 2022 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35841024
14.
A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention.
J Behav Med;
45(5): 771-781, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35930212
15.
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
Cancer;
127(14): 2545-2552, 2021 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33793979
16.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer;
127(24): 4546-4556, 2021 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34726788
17.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med;
379(2): 111-121, 2018 Jul 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29860917
18.
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Radiology;
301(1): 66-77, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34342501
19.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol;
21(10): 1317-1330, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32866432
20.
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Oncologist;
25(5): e798-e807, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31852811